CompanyDrug

Allist Pharmaceuticals’ Furmonertinib and AstraZeneca’s Enhertu Earn Breakthrough Designations in China for NSCLC Treatments

CompanyDrug

Thederma’s TAP-1503 Cream Receives Priority Review Status for Pediatric Atopic Dermatitis Treatment in China

CompanyDrug

Innovent Biologics’ Mazdutide Achieves Positive Results in Phase III Clinical Trial for Overweight or Obesity

CompanyDeals

Bain Capital-Backed Tenacia Strikes Deal with Praxis Precision Medicines for Essential Tremor Treatment

CompanyDrug

Abbisko Therapeutics’ Pimicotinib Earns Orphan Drug Designation from EMA for TGCT Treatment

CompanyDrug

Gilead’s Descovy Receives Additional Indication Approval from China’s NMPA for HIV-1 PrEP

CompanyDeals

Bebig Medical Group Secures Over USD 14 Million in Series B Financing to Boost Radiotherapy Technology

CompanyDeals

Chengdu Kanghua Strikes Licensing Deal with HilleVax for Recombinant Norovirus Vaccine

CompanyDrug

CSBIO’s Multi-Kinase Inhibitor CSCJC3456 Gets Green Light for Clinical Trials in Advanced Solid Tumors

CompanyDeals

Triastek Partners with Kangerjia to Develop 3D-Printed Modified Drugs for Sleep Disorders

CompanyDrug

Aidea Pharmaceutical Receives NMPA Approval to Clinically Test HIV-1 Treatment ACC017

Company

WuXi Biologics Expands Manufacturing Capacity to 36,000 Liters at Worcester Facility